Results 91 to 100 of about 23,536 (214)

Further evidence that scopolamine can improve verbal fluency

open access: yes, 1993
Scopolamine usually is found to impair various aspects of human cognitive performance. Recently, however, a significant (though modest) improvement in verbal fluency has been reported following scopolamine hydrobromide (0.6 and 1.2 mg p.o.).
Kemp, R.   +9 more
core   +1 more source

The neuroprotective effects of Ocimum gratissimum-supplemented diet on scopolamine-induced memory impairment in mice model of Alzheimer’s Disease

open access: yesPhytomedicine Plus
Background: Cognitive decline is a hallmark of Alzheimer's disease, a progressive neurodegenerative illness primarily caused by the buildup of amyloid plaque, which is brought on by oxidative stress and neuroinflammation.
Damilare Alabi Akanbi   +6 more
doaj   +1 more source

The Effect of Transdermal Scopolamine for the Prevention of Postoperative Nausea and Vomiting

open access: yesFrontiers in Pharmacology, 2014
Postoperative nausea and vomiting is one of the most common and undesirable complaints recorded in as many as 70%-80% of high-risk surgical patients. The current prophylactic therapy recommendations for PONV management stated in the Society of Ambulatory
Maria A. Antor   +7 more
doaj   +1 more source

Scopolamine (hyoscine) for preventing and treating motion sickness

open access: yes, 2004
Background: Motion sickness ‐ the discomfort experienced when perceived motion disturbs the organs of balance ‐ may include symptoms such as nausea, vomiting, pallor, cold sweats, hypersalivation, hyperventilation and headaches.
Spinks, Anneliese   +7 more
core   +1 more source

Vitamin E can compensate the density of M1 receptors in the hippocampus of scopolamine-treated rats

open access: yesFolia Neuropathologica, 2018
M1 muscarinic receptor plays a fundamental role in memory and is closely associated with Alzheimer’s disease (AD); it has long been assumed as a therapeutic goal. By activating of the cholinergic receptor vitamin E helps with memory retention.
Ali Sayyahi   +3 more
doaj   +1 more source

The solid-state structures of (-)-scopolamine free base, (-)-scopolamine methobromide, (-)-scopolamine hydrobromide trihydrate, and of the pseudopolymorphic forms of (-)-scopolamine hydrochloride anhydrate and 1.66hydrate

open access: yes, 2000
(-)-Scopolamine hydrochloride anhydrate gives crystals belonging to the orthorhombic space group P212121 and at 293(2) K: a = 7.097(2), b = 10.686(2), c = 22.623(2) Å, V = 1715.7(6) Å3, Z = 4, R(F) = 0.039, and Rw(F) = 0.053.
Dror Shiftan, Marc Drouin, Robert Glaser
core   +1 more source

Persistent Effects of Prenatally Administered Scopolamine

open access: yes, 1980
Acute effects of anticholinergic drugs on behavior are well documented (Warburton, 1975); however, evidence of chronic effects of these drugs administered prenatally is practically nonexistent.
Linda Ramirez, Michael E. Campbell
core   +1 more source

Visual side effects from transdermal scopolamine (Hyoscine)

open access: yes, 2006
Transdermal scopolamine may be used to reduce sialorrhea in children with special needs. Side effects include dilated pupils and reduced accommodation.
Firth, A.Y.   +3 more
core   +1 more source

NMR Data Set Brominated Scopolamine Derivatives

open access: yes
Raw NMR spectra data for characterizing scopolamine hydrobromide (SHBr) and scopolamine N-butyl bromide (SBBr) at pH
Matamala-Troncoso, Felipe
core   +1 more source

Scopolamine for preventing and treating motion sickness

open access: yes, 2004
BACKGROUND: Motion sickness - the discomfort experienced when perceived motion disturbs the organs of balance - may include symptoms such as nausea, vomiting, pallor, cold sweats, hypersalivation, hyperventilation and headaches.
Wasiak, J.   +3 more
core  

Home - About - Disclaimer - Privacy